Safety, Tolerability, and Effect of Nusinersen Treatment in Ambulatory Adults With 5q-SMA
Objective: To determine the safety and tolerability of nusinersen treatment in ambulatory adults with spinal muscular atrophy (SMA) and investigate the treatment effect on muscle strength, physical function, and motor unit physiology.Methods: Individuals aged 18 years or older with genetically confi...
Main Authors: | Bakri Elsheikh, Steven Severyn, Songzhu Zhao, David Kline, Matthew Linsenmayer, Kristina Kelly, Marco Tellez, Amy Bartlett, Sarah Heintzman, Jerry Reynolds, Gary Sterling, Tristan Weaver, Kiran Rajneesh, Stephen J. Kolb, W. David Arnold |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2021.650535/full |
Similar Items
-
Safety, Tolerability, and Effect of Nusinersen in Non-ambulatory Adults With Spinal Muscular Atrophy
by: Bakri Elsheikh, et al.
Published: (2021-04-01) -
Effect of the COVID-19 Pandemic on Children With SMA Receiving Nusinersen: What Is Missed and What Is Gained?
by: Caterina Agosto, et al.
Published: (2021-09-01) -
Anestesia para colocación de nusinersen intratecal en pacientes con atrofia muscular espinal
by: Silvina Longo, et al.
Published: (2021-07-01) -
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
by: Maren Freigang, et al.
Published: (2021-07-01) -
Circulating MyomiRs as Potential Biomarkers to Monitor Response to Nusinersen in Pediatric SMA Patients
by: Silvia Bonanno, et al.
Published: (2020-01-01)